Daxor Corporation (DXR) Stock Analysis

Company Overview

Daxor Corporation (DXR) carries a market capitalisation of $59.96M. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry.

The most recent close on file for DXR is $10.27, dated September 4, 2026. That is −$0.28 (−2.65%) against the previous close. Over the past 52 weeks the price has ranged from $8.56 to $14.76. The latest close sits 19.98% above that 52-week low.

Financial Health

In fiscal 2025, Daxor Corporation reported revenue of $10.30M. Against the prior fiscal year total of $2.13M, that is a change of +383.53%. The same year closed with net income of $9.17M. That is +1,609.71% against the prior fiscal year. Profit margin runs at 34,359.16%. That is 34,358.3 percentage points above the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to 1.69.

Across the 4 fiscal years on file, revenue moves from $6.31M in 2022 to $10.30M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 6.08. That is 0.2 times the Medical Instruments & Supplies median of 35.61. Measured against sales, the shares trade at 2,246.65 times revenue. On price-to-sales that is 708.1 times the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.27. Daily returns over the trailing 10 years annualize to a volatility of 79.21%. Over the trailing twelve months the price has returned −9.36%. Across 10 years the annualized return works out at +2.64%.

Growth & Income

No dividend is on file for DXR.

2026 is still running; the price is −30.37% year to date. Across the complete calendar years on file, 2025 returned +91.81% and 2017 returned −44.54%. Of the 9 complete calendar years on file, 5 finished higher.